Active, Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
- Locations
-
- Institut de cancérologie de l'Ouest Angers, France
- Clinique Sainte Catherine Avignon, France
- Centre Hospitalier de la Côte Basque Bayonne, France
- CHU Bordeaux - Hôpial Saint André Bordeaux, France